Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | KCNJ11 | Q14654 | 12/20 | 0.41 |
| ▸ | ABCC9 | O60706 | 6/20 | 0.41 |
| ▸ | ABCC8 | Q09428 | 6/20 | 0.41 |
| ▸ | KCNJ8 | Q15842 | 6/20 | 0.41 |
| ▸ | MLYCD | O95822 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27546633 | 0.82 | IDO1 (0.52) | KDM4EKMT2AALDH1A1POLBATM | |
| SCHEMBL24440219 | 0.79 | GABRA1 (0.42) | KDM4EMEN1MAPTKMT2AALDH1A1 | |
| SCHEMBL28896167 | 0.77 | ALDH1A1 (0.39) | ALDH1A1ATMIDO1 | |
| SCHEMBL7559119 | 0.73 | TAAR1 (0.41) | IDO1 | |
| SCHEMBL2582219 | 0.71 | MEN1 (0.52) | KDM4EMEN1MAPTKMT2AALDH1A1 | |
| SCHEMBL12954591 | 0.69 | TAAR1 (0.56) | MEN1MAPTKMT2AALDH1A1LMNA | |
| SCHEMBL1044190 | 0.69 | TAAR1 (0.54) | KDM4EMAPTHSD17B10IDO1 | |
| SCHEMBL1044191 | 0.69 | TAAR1 (0.54) | KDM4EMAPTHSD17B10IDO1 | |
| SCHEMBL11456607 | 0.69 | TAAR1 (0.56) | MEN1MAPTKMT2AALDH1A1LMNA | |
| SCHEMBL27609943 | 0.68 | IDO1 (0.47) | KDM4EKMT2AALDH1A1POLBATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230303600-A1 | TETHERED ALKYLIDENE AND METHODS OF MAKING THE SAME | NATIONAL SCIENCE FOUNDATION | 2023-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230303600-A1 | TETHERED ALKYLIDENE AND METHODS OF MAKING THE SAME | CYCS, DNMT1, CCNY | KDM4E 2397/4885MEN1 225/4885MAPT 3683/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.